The Valencian Community transparently offers penetration data for biosimilar medicines, which reach a market share of 45 percent. This was revealed in the drafting meeting 'Biosimilar Medicines. Access routes to innovation in C. Valenciana', sponsored by BioSim.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
